What is Antisynthetase syndrome

Antisynthetase syndrome is a rare, chronic autoimmune disorder characterized by the presence of specific autoantibodies, most notably anti-Jo-1, and a clinical triad of interstitial lung disease, inflammatory myositis (muscle inflammation), and arthritis. It is a systemic condition that requires specialized, multidisciplinary care to manage its impact on the lungs, joints, and muscular system.

What exactly is Antisynthetase syndrome?

Antisynthetase syndrome is a distinct subset of idiopathic inflammatory myopathies. Unlike other forms of myositis, this condition is defined by the body’s immune system mistakenly attacking aminoacyl-tRNA synthetases—enzymes essential for protein synthesis. Because these enzymes are present in cells throughout the body, Antisynthetase syndrome can affect multiple organ systems simultaneously, leading to a complex and highly variable clinical presentation.

How does Antisynthetase syndrome affect the body?

The clinical impact of Antisynthetase syndrome is broad. While many patients experience muscle weakness and lung involvement, the severity and order of symptom onset vary significantly between individuals. Key clinical manifestations include:

• Interstitial Lung Disease (ILD): Present in up to 70–90% of patients, often serving as the most significant factor affecting long-term prognosis.


• Inflammatory Myositis: Characterized by symmetrical weakness, particularly in the shoulders and hips.


• Arthritis: Typically non-erosive and affecting the small joints of the hands.


• "Mechanic’s Hands": A specific skin manifestation involving hyperkeratosis, fissuring, and scaling of the fingertips.


• Raynaud’s Phenomenon: Sensitivity to cold causing color changes in the fingers and toes.

Who is typically affected by Antisynthetase syndrome?

Antisynthetase syndrome is considered a rare disease, though exact global prevalence data remains elusive due to historical diagnostic challenges. It most commonly affects adults between the ages of 40 and 60. Clinical data suggests a higher prevalence in women compared to men, with a ratio of approximately 2:1. While Antisynthetase syndrome occurs worldwide, there is no evidence suggesting it is limited to specific geographic regions or ethnic groups.

What differentiates this condition from other autoimmune diseases?

The defining feature of Antisynthetase syndrome is the presence of anti-synthetase antibodies (most commonly anti-Jo-1). While it shares features with dermatomyositis and polymyositis, the specific involvement of the lungs and the presence of the "mechanic's hands" symptom help clinicians differentiate it from other rheumatologic conditions. At DiseaseMaps.org, 36 people with Antisynthetase syndrome have joined the community to share their experiences, highlighting the importance of peer support in navigating this complex diagnosis.

Next steps

• Consult a rheumatologist with specific expertise in interstitial lung disease and myositis.


• Undergo pulmonary function testing and high-resolution computed tomography (HRCT) to assess lung involvement.


• Connect with the community on DiseaseMaps.org to share experiences and learn from others living with this condition.


• Discuss potential clinical trials or research registries with your specialist to contribute to the growing body of knowledge on this syndrome.

Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• Orphanet (ORPHA: 206660): Antisynthetase syndrome.


• NIH Genetic and Rare Diseases Information Center (GARD): Antisynthetase syndrome overview.


• OMIM (Online Mendelian Inheritance in Man): Entry for antisynthetase syndrome-related autoantibodies.


• The Myositis Association: Clinical resources and patient support for inflammatory myopathies.